Valuation (74%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 22.83 | 17.33 |
PEG Ratio (TTM) | 2.31 | 6.52 |
P/S Ratio (TTM) | 8.67 | 3.05 |
P/B Ratio (TTM) | 2.68 | -5.27 |
P/FCF Ratio (TTM) | 14.83 | 24.28 |
Price to 5YR AVG Earnings Ratio | 10.71 | 32.98 |
Price to 5YR AVG FCF Ratio | 10.20 | 19.45 |
Profitability (60%) |
Company | Industry |
---|---|---|
ROA (TTM) | 4.18% | 6.06% |
ROE (TTM) | 11.86% | -713.63% |
Net Profit Margin (TTM) | 37.99% | 18.18% |
ROIC 5YR AVG | 10.25% | 9.15% |
Growth (40%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 15.22% | -8.19% | 0.60% |
Revenue | 1.76% | 3.37% | 4.03% |
Net Income | 15.01% | -2.25% | 4.04% |
Cash Flow | 4.01% | 10.22% | 7.28% |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.11 | 1.01 |
Quick Ratio (TTM) | 2.15 | 0.87 |
D/E Ratio (TTM) | 1.53 | -2.98 |
Interest Coverage (TTM) | -146.75 | 3.10 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | 1.17 | 1.61 |
LTL to 5YR AVG FCF | 6.39 | 5.56 |
Shares Outstanding Growth 5YR AVG | 9.95% | 7.91% |